Clofarabine plus low-dose cytarabine is as effective as and less toxic than intensive chemotherapy in elderly AML patients

Most patient with acute myeloid leukemia (AML) age ≥ 60 are not offered intensive induction because of high mortality. Phase 2 studies of clofarabine plus low-dose cytarabine (CLDA) as frontline therapy for elderly AML patients demonstrated high response and acceptable toxicity. We hypothesized that...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Clin Lymphoma Myeloma Leuk
Asıl Yazarlar: Takahashi, Koichi, Kantarjian, Hagop, Garcia-Manero, Guillermo, Borthakur, Gautam, Kadia, Tapan, DiNardo, Courtney, Jabbour, Elias, Pierce, Sherry, Estrov, Zeev, Konopleva, Marina, Andreeff, Michael, Ravandi, Farhad, Cortes, Jorge
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2015
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4804759/
https://ncbi.nlm.nih.gov/pubmed/26752456
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clml.2015.11.016
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller